Latest Breaking News On - Robertg shawah - Page 1 : comparemela.com

Acurx Pharmaceuticals, Inc Reports First Quarter 2024 Results and Provides Business Update

Acurx Pharmaceuticals, Inc Reports First Quarter 2024 Results and Provides Business Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRobertg shawahDavidp luciKevin gareyAcurx pharmaceuticalsInternational cdifficile symposiumEuropean medicines agencyPrnewswire acurx pharmaceuticals incAcurx pharmaceuticals incAnaerobe society of americaDrug administrationInfectious diseases society of americaUniversity of houston college pharmacyEuropean society of microbiologyExchange commission on formMarketing authorization

Acurx Pharmaceuticals, Inc to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

STATEN ISLAND, N.Y., April 23, 2024 /PRNewswire/ Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial.

Robertg shawahDavidp luciPrnewswire acurx pharmaceuticals incDrug administrationAcurx pharmaceuticalsAcurx pharmaceuticals incExchange commission on formChief executive officerChief financial officerGram positive selective spectrumQualified infectious disease productGenerating new antibiotic incentives nowLooking statementsPrivate securities litigation reform actExchange commission

Acurx Pharmaceuticals to Discuss Third Quarter 2023 Financial Results and Provide Business Update

STATEN ISLAND, N.Y., Oct. 25, 2023 /PRNewswire/ Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial.

United statesRobertg shawahDavidp luciTrial oversight committeeSociety or healthcare epidemiology of americaDiseases society of americaAcurx pharmaceuticals incDrug administrationPrnewswire acurx pharmaceuticals incAcurx pharmaceuticalsChief executive officerChief financial officerIbezapolstat phaseBile acidClinical practice guidelinesDiseases society

Acurx Pharmaceuticals, Inc Reports Second Quarter 2023 Results and Provides Business Update

STATEN ISLAND, N.Y., Aug. 14, 2023 /PRNewswire/ Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial. -Today at 07:02 am- MarketScreener

United statesUrsula theuretzbacherRobertg shawahBob delucciaDavidp luciKevin gareySociety or healthcare epidemiology of americaTrial oversight committeeExchange commissionUniversity of houston college pharmacyPrnewswire acurx pharmaceuticals incEuropean congressDrug administrationLeiden university medical center hollandInfectious disease society of america bostonAcurx pharmaceuticals inc

Acurx Pharmaceuticals to Discuss Second Quarter 2023 Financial Results and Provide Business Update

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of.

United statesDavidp luciRobertg shawahTrial oversight committeeDrug administrationDiseases society of americaPrnewswire acurx pharmaceuticals incAcurx pharmaceuticals incSociety or healthcare epidemiology of americaAcurx pharmaceuticalsChief executive officerChief financial officerIbezapolstat phaseBile acidClinical practice guidelinesDiseases society